Pure red cell aplasia and hypogammaglobulinemia in a patient with thymoma.

J Chin Med Assoc

Division of Thoracic Surgery, Department of Surgery, Keelung Hospital, Department of Health Executive Yuan, Keelung, Taipei, Taiwan, R.O.C.

Published: January 2009

Both pure red cell aplasia (PRCA) and hypogammaglobulinemia are rarer conditions than myasthenia gravis (MG) in thymoma patients. Several articles have discussed the relation between PRCA and thymoma or hypogammaglobulinemia and thymoma, and their proper treatments. Instances of both PRCA and hypogammaglobulinemia in a thymoma patient are few and reported sporadically in the literature. We discuss a 46-year-old woman with thymoma and simultaneous PRCA and hypogammaglobulinemia who achieved complete remission from PRCA after perioperative steroid administration and extended thymectomy, and review the literature.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1726-4901(09)70017-6DOI Listing

Publication Analysis

Top Keywords

prca hypogammaglobulinemia
12
pure red
8
red cell
8
cell aplasia
8
hypogammaglobulinemia thymoma
8
thymoma
6
hypogammaglobulinemia
5
prca
5
aplasia hypogammaglobulinemia
4
hypogammaglobulinemia patient
4

Similar Publications

Pure Red Cell Aplasia in a Patient with Thymic Hyperplasia, Hypogammaglobulinemia and Adult T-cell Leukemia/Lymphoma.

Intern Med

September 2024

Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan.

Article Synopsis
  • A 41-year-old man with no prior health issues presented with severe anemia, swollen lymph nodes, an upper mediastinal mass, and low antibody levels, leading to a diagnosis of pure red cell aplasia (PRCA) and adult T-cell leukemia/lymphoma (ATLL).
  • His mediastinal mass was identified as thymic hyperplasia, but it did not show evidence of ATLL invasion.
  • After surgery to remove the thymus, his anemia improved, but PRCA returned about 500 days later, indicating a potential link between his symptoms and ATLL, possibly as paraneoplastic syndromes.
View Article and Find Full Text PDF
Article Synopsis
  • - Good's syndrome is a rare condition that combines thymoma (a tumor of the thymus) and an immunoglobulin disorder, leading to various complications in patients.
  • - This report describes a patient with Good's syndrome who also had pure red cell aplasia (PRCA) and subclinical myasthenia gravis, where treatment with cyclosporine A improved PRCA but did not recover hypoglobulinemia or reduce anti-AChR antibodies.
  • - The literature review indicates that while cyclosporine A is effective for PRCA in Good's syndrome, it does not address hypoglobulinemia, suggesting different underlying mechanisms for these conditions, highlighting the need for further research.
View Article and Find Full Text PDF

Background: Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disease caused by mutations in the ADA2 gene. DADA2 has a broad spectrum of clinical presentations. Apart from systemic manifestations, we can categorize most of the signs and symptoms of DADA2 into the three groups of vasculitis, hematologic abnormalities, and immunologic dysregulations.

View Article and Find Full Text PDF

Thymoma presenting concurrent pure red-cell aplasia (PRCA) and hypogammaglobulinemia are extremely rare. A 67-year-old woman with a short of breath was referred to our hospital due to anemia and the chest abnormal shadow. Laboratory investigations revealed a hemoglobin level of 5.

View Article and Find Full Text PDF
Article Synopsis
  • DADA2 is a rare genetic disorder that has evolved in understanding since its discovery in 2014, now recognized for causing a range of symptoms affecting multiple body systems, including fevers, strokes, and skin issues.
  • A study of 60 patients revealed overlapping symptoms categorized into three main groups: inflammatory/vascular issues, immune dysregulation, and hematologic problems, with notable immune system deficiencies but low rates of infections.
  • The cohort's treatment experience included the use of anti-TNF therapy, which appeared effective in preventing strokes, and several patients underwent hematopoietic cell transplantation, all of whom are currently alive despite challenges such as graft failure.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!